"skipMainNavigation"
closeDrawerMenuopenDrawerMenu
Search
Quick Search in Journals
Quick Search anywhere
Advanced Search
Radiology
Menu
  • Information
    • Previous
    Next
    Original Research

    Reperfusion Is a Stronger Predictor of Good Clinical Outcome than Recanalization in Ischemic Stroke

    Published Online:Oct 1 2013https://doi.org/10.1148/radiol.13122327

    Abstract

    Reperfusion showed stronger association with good clinical outcome than did recanalization.

    Purpose

    To assess the predictive value of reperfusion indices, recanalization, and important baseline clinical and radiologic scores for good clinical outcome prediction.

    Materials and Methods

    The study was approved by the local research ethics board. Written consent was obtained from all participants or their caregivers. Baseline computed tomography (CT) perfusion less than 4.5 hours after stroke symptoms, follow-up CT perfusion at 24 hours or less, and 5–7-day magnetic resonance images were obtained for 114 patients. Baseline imaging was assessed blinded to outcome. Recanalization status was determined at follow-up CT angiography. Reperfusion index was calculated on baseline and on follow-up at-risk tissue volume. Kruskal-Wallis, Mann-Whitney rank sum, and Spearman correlation were used for group comparisons and correlation studies. Univariate and multivariate logistic regression tested the association of clinical and imaging parameters with good outcome. Models with and without recanalization and reperfusion were compared by using Akaike information criterion.

    Results

    Reperfusion indices were significantly higher in patients with recanalization than in those without (P < .001). Despite significance of recanalization at univariate analysis, only reperfusion, age, and National Institutes of Health Stroke Scale score were significant after multivariate analysis (P < .01). Time to maximum reperfusion index had the highest accuracy (area under the receiver operating characteristic curve, 0.70) for good outcome, and reperfusion was defined as time to maximum volume of 59% or greater. Patients with reperfusion but no recanalization had significantly lower total infarct volume (P = .001) and infarct growth (P = .004) and had higher salvaged penumbra (P = .009) volumes than patients without reperfusion and recanalization. A final model with reperfusion but not recanalization was the most prognostic model of good clinical outcome.

    Conclusion

    Reperfusion showed stronger association with good clinical outcome than did recanalization.

    © RSNA, 2013

    References

    • 1 Nogueira RG, Liebeskind DS, Sung G, et al.. Predictors of good clinical outcomes, mortality, and successful revascularization in patients with acute ischemic stroke undergoing thrombectomy: pooled analysis of the Mechanical Embolus Removal in Cerebral Ischemia (MERCI) and Multi MERCI Trials. Stroke 2009;40(12):3777–3783. Crossref, Medline, Google Scholar
    • 2 Rha JH, Saver JL. The impact of recanalization on ischemic stroke outcome: a meta-analysis. Stroke 2007;38(3):967–973. Crossref, Medline, Google Scholar
    • 3 Zaidat OO, Suarez JI, Sunshine JL, et al.. Thrombolytic therapy of acute ischemic stroke: correlation of angiographic recanalization with clinical outcome. AJNR Am J Neuroradiol 2005;26(4):880–884. Medline, Google Scholar
    • 4 del Zoppo GJ, Koziol JA. Recanalization and stroke outcome. Circulation 2007;115(20):2602–2605. Crossref, Medline, Google Scholar
    • 5 Mori E, Yoneda Y, Tabuchi M, et al.. Intravenous recombinant tissue plasminogen activator in acute carotid artery territory stroke. Neurology 1992;42(5):976–982. Crossref, Medline, Google Scholar
    • 6 Khatri P, Neff J, Broderick JP, et al.. Revascularization end points in stroke interventional trials: recanalization versus reperfusion in IMS-I. Stroke 2005;36(11):2400–2403. Crossref, Medline, Google Scholar
    • 7 Soares BP, Chien JD, Wintermark M. MR and CT monitoring of recanalization, reperfusion, and penumbra salvage: everything that recanalizes does not necessarily reperfuse! Stroke 2009;40(3 Suppl):S24–S27. Crossref, Medline, Google Scholar
    • 8 Tomsick T. TIMI, TIBI, TICI: I came, I saw, I got confused. AJNR Am J Neuroradiol 2007;28(2):382–384. Medline, Google Scholar
    • 9 del Zoppo GJ. Virchow’s triad: the vascular basis of cerebral injury. Rev Neurol Dis 2008;5(Suppl 1):S12–S21. Medline, Google Scholar
    • 10 Ames A, Wright RL, Kowada M, Thurston JM, Majno G. Cerebral ischemia. II. The no-reflow phenomenon. Am J Pathol 1968;52(2):437–453. Medline, Google Scholar
    • 11 Qureshi AI, Hussein HM, Abdelmoula M, Georgiadis AL, Janjua N. Subacute recanalization and reocclusion in patients with acute ischemic stroke following endovascular treatment. Neurocrit Care 2009;10(2):195–203. Crossref, Medline, Google Scholar
    • 12 Qureshi AI, Siddiqui AM, Kim SH, et al.. Reocclusion of recanalized arteries during intra-arterial thrombolysis for acute ischemic stroke. AJNR Am J Neuroradiol 2004;25(2):322–328. Medline, Google Scholar
    • 13 Alexandrov AV, Grotta JC. Arterial reocclusion in stroke patients treated with intravenous tissue plasminogen activator. Neurology 2002;59(6):862–867. Crossref, Medline, Google Scholar
    • 14 Soares BP, Tong E, Hom J, et al.. Reperfusion is a more accurate predictor of follow-up infarct volume than recanalization: a proof of concept using CT in acute ischemic stroke patients. Stroke 2010;41(1):e34–e40. Crossref, Medline, Google Scholar
    • 15 Kwiatkowski TG, Libman RB, Frankel M, et al.. Effects of tissue plasminogen activator for acute ischemic stroke at one year. National Institute of Neurological Disorders and Stroke Recombinant Tissue Plasminogen Activator Stroke Study Group. N Engl J Med 1999;340(23):1781–1787. Crossref, Medline, Google Scholar
    • 16 Bruno A, Biller J, Adams HP, et al.. Acute blood glucose level and outcome from ischemic stroke. Trial of ORG 10172 in Acute Stroke Treatment (TOAST) Investigators. Neurology 1999;52(2):280–284. Crossref, Medline, Google Scholar
    • 17 Generalized efficacy of t-PA for acute stroke. Subgroup analysis of the NINDS t-PA Stroke Trial. Stroke 1997;28(11):2119–2125. Crossref, Medline, Google Scholar
    • 18 Marler JR, Tilley BC, Lu M, et al.. Early stroke treatment associated with better outcome: the NINDS rt-PA stroke study. Neurology 2000;55(11):1649–1655. Crossref, Medline, Google Scholar
    • 19 Adams HP, Adams RJ, Brott T, et al.. Guidelines for the early management of patients with ischemic stroke: A scientific statement from the Stroke Council of the American Stroke Association. Stroke 2003;34(4):1056–1083. Crossref, Medline, Google Scholar
    • 20 Tissue plasminogen activator for acute ischemic stroke. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. N Engl J Med 1995;333(24):1581–1587. Crossref, Medline, Google Scholar
    • 21 Hacke W, Kaste M, Fieschi C, et al.. Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke. The European Cooperative Acute Stroke Study (ECASS). JAMA 1995;274(13):1017–1025. Crossref, Medline, Google Scholar
    • 22 Tan IY, Demchuk AM, Hopyan J, et al.. CT angiography clot burden score and collateral score: correlation with clinical and radiologic outcomes in acute middle cerebral artery infarct. AJNR Am J Neuroradiol 2009;30(3):525–531. Crossref, Medline, Google Scholar
    • 23 Puetz V, Dzialowski I, Hill MD, et al.. Intracranial thrombus extent predicts clinical outcome, final infarct size and hemorrhagic transformation in ischemic stroke: the clot burden score. Int J Stroke 2008;3(4):230–236. Crossref, Medline, Google Scholar
    • 24 Sillanpaa N, Saarinen JT, Rusanen H, et al.. The clot burden score, the Boston Acute Stroke Imaging Scale, the cerebral blood volume ASPECTS, and two novel imaging parameters in the prediction of clinical outcome of ischemic stroke patients receiving intravenous thrombolytic therapy. Neuroradiology 2012;54(7):663–672. Crossref, Medline, Google Scholar
    • 25 von Kummer R, Weber J. Brain and vascular imaging in acute ischemic stroke: the potential of computed tomography. Neurology 1997;49(5 Suppl 4):S52–S55. Crossref, Medline, Google Scholar
    • 26 Demchuk AM, Coutts SB. Alberta Stroke Program Early CT Score in acute stroke triage. Neuroimaging Clin N Am 2005;15(2):409–419, xii. Crossref, Medline, Google Scholar
    • 27 Kim JT, Park MS, Choi KH, et al.. The CBV-ASPECT Score as a predictor of fatal stroke in a hyperacute state. Eur Neurol 2010;63(6):357–363. Crossref, Medline, Google Scholar
    • 28 Murphy BD, Fox AJ, Lee DH, et al.. White matter thresholds for ischemic penumbra and infarct core in patients with acute stroke: CT perfusion study. Radiology 2008;247(3):818–825. Link, Google Scholar
    • 29 Barber PA, Demchuk AM, Zhang J, Buchan AM. Validity and reliability of a quantitative computed tomography score in predicting outcome of hyperacute stroke before throm bolytic therapy. ASPECTS Study Group. Alberta Stroke Programme Early CT Score. Lancet 2000;355(9216):1670–1674. Crossref, Medline, Google Scholar
    • 30 Kim JJ, Fischbein NJ, Lu Y, Pham D, Dillon WP. Regional angiographic grading system for collateral flow: correlation with cerebral infarction in patients with middle cerebral artery occlusion. Stroke 2004;35(6):1340–1344. Crossref, Medline, Google Scholar
    • 31 Kamalian S, Kamalian S, Maas MB, et al.. CT cerebral blood flow maps optimally correlate with admission diffusion-weighted imaging in acute stroke but thresholds vary by postprocessing platform. Stroke 2011;42(7):1923–1928. Crossref, Medline, Google Scholar
    • 32 Campbell BC, Christensen S, Levi CR, et al.. Cerebral blood flow is the optimal CT perfusion parameter for assessing infarct core. Stroke 2011;42(12):3435–3440. Crossref, Medline, Google Scholar
    • 33 Tamura A, Murakami K, Kadota J; OITA-GF Study Investigators. Prevalence and independent factors for gastroduodenal ulcers/erosions in asymptomatic patients taking low-dose aspirin and gastroprotective agents: the OITA-GF study. QJM 2011;104(2):133–139. Crossref, Medline, Google Scholar
    • 34 Meurer WJ, Scott PA, Caveney AF, et al.. Lack of association between hyperglycaemia at arrival and clinical outcomes in acute stroke patients treated with tissue plasminogen activator. Int J Stroke 2010;5(3):163–166. Crossref, Medline, Google Scholar
    • 35 Olivot J-M, Mlynash M, Thijs VN, et al.. Optimal Tmax threshold for predicting penumbral tissue in acute stroke. Stroke 2009;40(2):469–475. Crossref, Medline, Google Scholar
    • 36 Kamalian S, Kamalian S, Konstas AA, et al.. CT perfusion mean transit time maps optimally distinguish benign oligemia from true “at-risk” ischemic penumbra, but thresholds vary by postprocessing technique. AJNR Am J Neuroradiol 2012;33(3):545–549. Crossref, Medline, Google Scholar
    • 37 Leiva-Salinas C, Provenzale JM, Kudo K, Sasaki M, Wintermark M. The alphabet soup of perfusion CT and MR imaging: terminology revisited and clarified in five questions. Neuroradiology 2012;54(9):907–918. Crossref, Medline, Google Scholar
    • 38 Weimar C, König IR, Kraywinkel K, Ziegler A, Diener HC; German Stroke Study Collaboration. Age National Institutes of Health Stroke Scale Score within 6 hours after onset are accurate predictors of outcome after cerebral ischemia: development and external validation of prognostic models. Stroke 2004;35(1):158–162. Crossref, Medline, Google Scholar
    • 39 Murphy BD, Fox AJ, Lee DH, et al.. Identification of penumbra and infarct in acute ischemic stroke using computed tomography perfusion-derived blood flow and blood volume measurements. Stroke 2006;37(7):1771–1777. Crossref, Medline, Google Scholar
    • 40 van Everdingen KJ, van der Grond J, Kappelle LJ, Ramos LM, Mali WP. Diffusion-weighted magnetic resonance imaging in acute stroke. Stroke 1998;29(9):1783–1790 Crossref, Medline, Google Scholar
    • 41 Gaudinski MR, Henning EC, Miracle A, Luby M, Warach S, Latour LL. Establishing final infarct volume: stroke lesion evolution past 30 days is insignificant. Stroke 2008;39(10):2765–2768. Crossref, Medline, Google Scholar
    • 42 Diffusion Weighted Imaging Evaluation for Understanding Stroke Evolution Study-2 (DEFUSE-2)http://clinicaltrials.gov/show/NCT01349946. Accessed May 11, 2012. Google Scholar
    • 43 Broderick JP, Palesch YY, Demchuk AM, et al.. Endovascular therapy after intravenous t-PA versus t-PA alone for stroke. N Engl J Med 2013;368(10):893–903. Crossref, Medline, Google Scholar

    Article History

    Received October 18, 2012; revision requested December 27; revision received February 22, 2013; accepted March 11; final version accepted March 15.
    Published online: Oct 2013
    Published in print: Oct 2013